Table 2.
Cancer Cell Line/Xenograft | Mechanism | Cellular Effects |
---|---|---|
Colorectal cancer [41] | ERK/AKT-dependent signaling | Inhibition of migration |
A375 melanoma cells B16F10 melanoma cells [11,48] |
ERK1/2—dependent signaling | Reduction of metastatic foci by inhibition of transendothelial migration |
Malignant Pleural Mesothelioma [44] | ERK/AKT-dependent signaling; BAX, BCL2 factors |
Inhibition of proliferation and migration Promotion of apoptosis |
MGC803 gastric cancer cells [42] | ERK1/2—dependent signaling | Increased proliferation and migration |
Breast cancer cells line [43,45,49,52] | SPOCK1/testican 1-mediated signaling MAPK-signaling |
Increased expression of integrins, proliferation, 3D tumor growth and cells survival Angiogenesis |
Lung adenocarcinoma [50] | ERK/AKT-dependent signaling | Inhibition of apoptosis |